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Abstract
Background: The fetal immune system is characterized by a Th2 bias but it is unclear how the Th2 predominance is
established. Natural killer T (NKT) cells are a rare subset of T cells with immune regulatory functions and are already
activated in utero. To test the hypothesis that NKT cells are part of the regulatory network that sets the fetal Th2
predominance, percentages of Va24+Vb11+ NKT cells expressing Th1/Th2-related chemokine receptors (CKR) were assessed
in cord blood. Furthermore, IL-4 and IFN-c secreting NKT cells were quantified within the single CKR+ subsets.
Results: Cord blood NKT cells expressed the Th2-related CCR4 and CCR8 at significantly higher frequencies compared to
peripheral blood NKT cells from adults, while CXCR3+ and CCR5+ cord blood NKT cells (Th1-related) were present at lower
percentages. Within CD4negCD8neg (DN) NKT cells, the frequency of IL-4 producing NKT cells was significantly higher in cord
blood, while frequencies of IFN-c secreting DN NKT cells tended to be lower. A further subanalysis showed that the higher
percentage of IL-4 secreting DN NKT cells was restricted to CCR3+, CCR4+, CCR5+, CCR6+, CCR7+, CCR8+ and CXCR4+ DN
subsets in cord blood. This resulted in significantly decreased IFN-c /IL-4 ratios of CCR3+, CCR6+ and CCR8+ cord blood DN
NKT cells. Sequencing of VA24AJ18 T cell receptor (TCR) transcripts in sorted cord blood Va24Vb11 cells confirmed the
invariant TCR alpha-chain ruling out the possibility that these cells represent an unusual subset of conventional T cells.
Conclusions: Despite the heterogeneity of cord blood NKT cells, we observed a clear Th2-bias at the phenotypic and
functional level which was mainly found in the DN subset. Therefore, we speculate that NKT cells are important for the
initiation and control of the fetal Th2 environment which is needed to maintain tolerance towards self-antigens as well as
non-inherited maternal antigens.
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Introduction
The fetus is exposed to a unique environment and needs to
maintain tolerance both towards non-inherited maternal antigens
and self-antigens that arise during its development. During
pregnancy both maternal and fetal immunity are characterized
by a Th2-bias. This promotes reciprocal materno-fetal tolerance
and ensures fetal survival [1,2]. However, it is unclear how the
fetal Th2-predominance is established.
Natural Killer T (NKT) cells are a rare subset of highly
conserved T cells that are already activated in utero. They are
characterized by the simultaneous expression of a T cell receptor
(TCR) and the NK cell marker CD161 (NKR-P1A) which places
them at the interface of innate and adaptive immunity. Most
human peripheral blood NKT cells are CD4+ or CD42CD82
double negative (DN), while CD8+ NKT cells are less frequent
[3,4]. They further display an activated memory phenotype as
shown by surface expression of CD25hi, CD45ROhi, CD45RBlow
and CD62Llow [5,6,7]. A hallmark of NKT cells is their highly
restricted TCR alpha repertoire, with constant expression of the T
cell receptor alpha variable chain 24 (TCRAV24) gene segment
that rearranges almost exclusively with T cell receptor alpha chain
joining region 18 (TCRAJ18), which result in the pairing of T cell
receptor alpha chain 24 (Va24) and T cell receptor beta chain 11
(Vb11). Furthermore, the N-region of the TCRA chain does not
contain inserted nucleotides [8,9] although rare exceptions from
this rule have been described [8,10,11]. The TCR repertoire of
NKT cells is further restricted by the preferential pairing of
TCRAV24-AJ18 with polyclonal TCRBV11 transcripts that use
diverse TCRBJ gene segments and complementarity determining
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regions 3 (CDR3). Despite this strongly limited TCR repertoire
NKT cells regulate a broad range of immune responses including
the maintenance of tolerance [12] or the defense against bacterial
infections [13,14,15]. Although the mechanistic basis for the
regulatory function of NKT cells is incompletely understood, it is
mediated at least partly by the unique ability of NKT cells to
produce Th1 and Th2 cytokines rapidly and in high concentra-
tions [16,17,18,19].
NKT cells are also found in cord blood [5,6] where they already
express the surface markers associated with activation. This
suggests that NKT cells might regulate immune functions as early
as in fetal life. Therefore, we hypothesized that cord blood NKT
cells possess unique regulatory functions that first, are distinct from
those of adult blood and second help to set the Th2 predominance.
To test this hypothesis, we performed a comprehensive analysis
of homeostatic and inflammatory chemokine receptors expressed
on cord blood NKT cells as compared to peripheral blood NKT
cells from adults and further determined the frequencies of




Peripheral blood was drawn from 28 healthy, non-smoking
adult volunteers without allergic disease (median age 27 yrs; range
23–45; 12 males, 13 females). In addition, a peripheral blood
count was performed in EDTA-blood to exclude infection and
samples with low lymphocyte counts.
Cord blood was obtained from 29 healthy, vaginally delivered
term newborns. Newborns who were small or large for gestational
age, with APGAR 10 min #7, obvious malformations or with
clinically suspected infection or maternal signs of infection sub partu
(fever.38.5u, leucocytosis.15.000/ml, CRP.20mg/dl) were ex-
cluded a priori. To control for contamination with maternal blood
only cord serum IgA was determined (below detection limit of
4.2 mg/dl). A cord blood count was performed in EDTA-blood to
further exclude anemia and/or infection. Written informed consent
was obtained from the mothers. The study protocol was approved
by the local Ethics Committee of the Bavarian College of
Physicians. All clinical investigations have been conducted accord-
ing to the principles of the Declaration of Helsinki.
Flow cytometry
To assess the chemokine receptors on the surface of NKT cells
four-color flow cytometry (FACS Calibur, Becton-Dickinson,
Heidelberg, Germany) was performed on freshly isolated mono-
nuclear cells from cord blood and peripheral blood from adults.
NKT cells were detected with mouse Va24-FITC, biotinylated
mouse Vb11 (Beckmann Coulter, Krefeld, Germany) and
strepavidin-allophycocyanin (APC) (Becton-Dickinson). For che-
mokine receptor analysis mouse anti-CCR1, -CCR2, -CCR6,
-CCR7, -CCR8, -CCR9, -CXCR3, -CXCR4, -CXCR5,
-CXCR6 coupled to phycoerythrin (PE) (all from R&D,
Wiesbaden), anti-CCR4-PE, anti-CCR5-PE, and anti-CD45RO-
PE (Becton-Dickinson) were used in combination with mouse
CD4-phycoerythrin-cyanine 5 (PC5) or with CD8-PC5 (IQ-
Products, Groningen). For the assessment of intracellular cytokines
(see below) six color flow-cytometry (FACS CANTO, Becton-
Dickinson) was performed using mouse anti-CD8 coupled to the
tandem dye peridinin-chlorophyll protein-cyanine-dye5.5 (PerCP-
Cy5.5), mouse CD4 APC-cyanine dye 7 (Cy7) (Becton Dickinson)
and rat anti-CCR3, CCR8) or mouse CKR-antibodies coupled to
APC (all R&D, Wiesbaden). Biotinylated mouse Vb11 was
detected with strepavidin-PE-Cy7. Color matched mouse IgG1,
mouse IgG2a, mouse and rat IgG2b were used as isotype controls.
A median of 3.956105 and 7.926105 lymphocytes was acquired in
adults and cord blood. To determine the percentages of
Va24+Vb11+ positive NKT cells, lymphocytes were first gated
according to their forward/side-scatter characteristics. A second
gate was set on Va24+Vb11+ lymphocytes and the percentage of
chemokine receptor positive cells was calculated within CD4+ and
CD8+ NKT cell subsets, after defining a cutoff value according to
the isotype controls. Data were analyzed with BD FACS DIVA
Software version 5.0.3.; Becton Dickinson).
Induction of intracellular cytokine production
Mononuclear cells were stimulated with phorbol myristate
acetate (PMA) (10 ng/ml) and ionomycine (0.75 mg/ml) in the
presence of 10 mg/ml brefeldin A for 3.5 hours (IL-4, IFN-c, IL-
13) or 24 h (IL-10) in VLE-RPMI 1640 followed by a fixation step
for 10 min at room temperature with Cellfix (Becton Dickinson).
After permeabilization with 0.5% saponin solution for 10 min at
4uC cells were stained with PE-conjugated monoclonal antibodies
directed against the respective cytokines. To minimize intraobser-
ver variations the cytokine data were analyzed two times at
different occasions and mean values were calculated.
N-region analysis of isolated NKT cells
NKT cells were highly enriched by FACS sorting (MoFlo XDP,
Beckman Coulter, FL, USA) and processed immediately after
sorting. Total mRNA was extracted using RNEasy MicroKit
(QIAGEN, Hilden) according to the manufacturer’s instruction
with a QIA Cube (QIAGEN) and immediately reverse transcribed
using random hexamer priming (Reverse Transcriptase Primer
Mix, QIAGEN). Contamination with genomic DNA was excluded
by RNA controls without reverse transcriptase in the cDNA
synthesis reaction. AV24-AJ18 transcripts were amplified using
AV24 59-GAA CTG CAC TCT TCA ATG C-39and AJ18 59-
TCC AAA GTA TAG CCT CCC CAG-39 as forward and
reverse primers (Metabion, Martinsried). PCRs were run on a
TGradient (Biometra, Go¨ttingen) for 3 min at 95uC, followed by
37 cycles (40 sec at 94uC, 40 sec at 59.7uC) and 1 min at 72uC
using Taq-Polymerase (Roche, Penzberg). Amplicons were
sequenced by MWG Eurofins (Martinsried, Munich, Germany).
Statistical analysis
Due to the low frequency of NKT cells a normal distribution
could not be expected. Therefore, Mann-Whitney U test was used
to analyze differences between NKT cells from adult peripheral
blood and cord blood. A probability of p#0.05 was regarded as
statistically significant. Statistical analyses were performed with
Prism 5.0 (GraphPad Software, Inc. La Jolla, CA 92037 USA).
Results
Chemokine receptor expression patterns of cord blood
Va24+ Vb11+ NKT cells
The frequency of cord blood NKT cells, defined as the Va24+
Vb11+ cells, within all lymphocytes ranged from 0.02–0.12%
(median 0.05%) and tended to be higher than in peripheral NKT
cells from adults (median 0.07%; range 0.01–0.23%). In cord
blood, the percentage of CD4+ NKT within all Va24+ Vb11+
NKT cells was significantly higher as compared to peripheral
blood from adults (median 89.7%, range 70.7–99.3% versus
17.8%, range 4.6–45.5%; p,0.0001), while CD8+ NKT cells did
not differ between both groups (median 6.2% versus 5.3%). In a
first step, we examined whether a panel of chemokine receptors is
Cord Blood Natural Killer T Cells
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differentially expressed on cord blood versus peripheral NKT cells:
cord blood NKT cells expressed the Th2-associated chemokine
receptors CCR4 and CCR8 at significantly higher frequencies
compared to NKT cells from adults, while the frequency of cord
blood NKT cells bearing the Th1-associated CXCR3 or CCR5
was lower (significant for CCR5 only). Further, percentages of
CCR7+, CCR9+, CXCR5+ and CXCR6+ NKT cells were
significantly higher in cord blood. Percentages of CD45RO
expressing NKT cells were lower in cord blood (Table 1).
Cytokine secretion within specific chemokine receptor
expressing NKT cell subsets
Since chemokine receptor analyses in total NKT cells indicated a
Th2-bias in the cord blood NKT cells, we set up a second series of
experiments to assess the cytokine production of total NKT cells and
single CKR+ NKT subsets by six color flow cytometry. Cord blood
total NKT cells produced IL-4 at significantly higher frequencies
than peripheral NKT cell, whereas production of IFN-c was similar
(Figure 1 and 2). Since this pointed to a Th2-bias in total NKT
cells intracellular staining was performed additionally for IL-13 and
IL-10. The frequency of IL-10 secreting NKT cells was highly
variable in cord blood (n = 3: 0%; 2.1% and 33%) and barely
detectable in NKT cells from adults (n = 3: 0%; 1.3%; 1.5%). The
frequency of IL-13 secreting NKT cells was higher in cord blood
(1.3%, 13.1%, 14.3%; versus 1.06%, 2.17%, 2.6%) thereby
supporting the presence of a Th2-bias in cord blood NKT cells.
A further subanalysis of the major NKT subpopulations showed
that the frequency of IFN-c producing cells tended to be lower in
the cord blood DN NKT population, while the frequency of IL-4
producing NKT cells was significantly higher compared to NKT
cells from adults. Among the CD4+ NKT cells the frequency of
IFN-c producing cord blood NKT was significantly lower
(p = 0.048) compared to NKT cells from adults, while the
frequency of IL-4 producing cells did not differ. Thus, overall
Table 1. Percentages of chemokine receptor expressing
Va24+Vb11+ NKT cells.
Cord blood Peripheral blood p-value
CCR1 57.08a (38.78–72.73) 54.58 (37.36–61.97) 0.48
CCR2 51.38 (32.30–58.73) 48.75 (28.57–63.69 0.97
CCR4 83.3 (71.8–90.4) 17.6 (7.3–37.6) ,0.0001
CCR5 47.28 (27.87–56.80) 79.78 (73.53–91.42) ,0.0001
CCR6 44.96 (41.36–63.21) 43.50 (9.23–55.00) 0.48
CCR7 90.50 (66.67–97.78) 43.67 (31.35–57.63) ,0.0001
CCR8 54.05 (32.00–77.78) 35.95 (11.02–55.05) 0.03
CCR9 10.68 (4.35–17.19) 4.98 (0.48–12.06) 0.01
CXCR3 83.09 (69.28–99.17) 94.09 (81.12–96.94) 0.13
CXCR4 86.27 (69.77–99.17) 84.30 (56.90–100.00) 0.60
CXCR5 40.00 (26.22–43.88) 31.48 (23.66–38.87) 0.03
CXCR6 54.29 (50.00–66.13) 48.28 (34.47–54.55) ,0.01
CD45RO 92.86 (88.75–97.20) 98.00 (94.83–100.00) ,0.002
aData are shown as medians with (min-max.).
doi:10.1371/journal.pone.0015714.t001
Figure 1. Percentages of IL-4 and IFN-c secreting NKT cells within total, CD4+ and DN subsets. Horizontal bars indicate medians of
percentages of IFN-c (upper panel) and IL-4 (lower panel) secreting NKT cells within total (left), DN (middle) and CD4+ (right) NKT cell subsets. Cord
blood (CB) NKT cells and peripheral blood (PB) NKT cells from adults are compared.
doi:10.1371/journal.pone.0015714.g001
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there was a Th2-bias in the dominant NKT subpopulations in
cord blood.
As expected, PMA/ionomycin stimulation led to a marked
downregulation of surface CKR expression; yet it was possible to
identify CKR expressing NKT cell subsets in sufficient numbers
for analyses.
Among DN NKT cells, the frequency of IL-4 producing cells
was significantly higher within CCR3+, CCR4+, CCR5+, CCR6+,
CCR7+, CCR8+ and CXCR4+ subsets in cord blood compared to
their peripheral blood counterparts from adults (Table 2). Within
DN NKT cells, a higher frequency of IFN-c producing cells could
be detected in CCR4+, CCR7+ and CXCR4+ cord blood NKT
cells. Among the CD4+subsets, IL-4 secreting cells were more
frequent in CXCR3+ NKT cells from adults. This resulted in
significantly lower IFN-c/IL-4 ratios for CCR3+ (p = 0.01),
CCR6+ (p,0.001) and CCR8+ (p = 0.03) DN NKT cells and also
for CCR6+ CD4+ NKT cells (p = 0.05) in cord blood.
Confirmation of invariant Va24+ chain in cord blood
To rule out the possibility that cord blood Va24+Vb11+ T cells
represent an unusual subset of conventional T cells with non-
invariant TCR alpha, we sorted Va24+Vb11+ T cells from six
cord blood samples and from adult peripheral blood. Sequencing
of AV24-AJ18 transcripts showed the characteristic rearrangement
without N-additions also in cord blood NKT cells. Further sorting
of NKT cells into DN, CD4+ and CD8+ populations confirmed
again the absence of N-additions in cord blood Va24+Vb11+
CD4+ NKT cells (Table 3). Due to the low frequency of DN and
Figure 2. Representative dot-plots of IL-4 and IFN-c secreting NKT cells within total, CD4+ and DN subsets. NKT cells from adult
peripheral blood (upper two panels) and cord blood NKT cells (lower two panels) are compared. NKT cells were first identified by double positive
staining of Va24 and Vb11 TCR chains (left). IFN-c and IL-4 secreting NKT cells are shown within total (left), DN (middle) and CD4+ (right) NKT cell
subsets.
doi:10.1371/journal.pone.0015714.g002
Cord Blood Natural Killer T Cells
PLoS ONE | www.plosone.org 4 January 2011 | Volume 6 | Issue 1 | e15714
CD8+ cord blood NKT cells it was not possible sort sufficient cells
for sequencing.
Discussion
The present study shows that human cord blood Va24+Vb11+
NKT exhibit a strong bias towards Th2-responses which is
restricted to specific NKT subsets which are distinguished by the
expression of chemokine receptors and the absence of CD4.
NKT cells were defined by the coexpression of Va24 and Vb11
TCR chains. We considered this definition as most suitable for
cord blood NKT cells, since CD161 is expressed at low levels in
cord blood NKT cells [20,21] (and own observations). Further,
conventional T cells can also express CD161 upon stimulation
[10,22]. The definition of NKT cells by their responsiveness to
glycolipids is also non-exclusive, because CD1d restricted cells that
do not use Va24 may also respond [23,24,25,26]. Furthermore,
our definition of NKT cells appears valid, since TCR sequencing
of sorted cord blood NKT confirmed the typical invariant Va24-
Ja18 TCR chain without N-additions.
Similar to peripheral blood NKT cells from adults, cord blood
NKT cells expressed a broad range of chemokine receptors that
can direct migration both to lymphoid and non-lymphoid tissues.
With the exception of CXCR5 our findings on peripheral blood
NKT cells match those of Kim et al.[27] very closely. Peripheral
blood NKT cells from adult donors have a predominant Th1/
inflammatory chemokine receptor profile [4,27,28]. This is
contrasted by higher frequencies of Th2-associated CCR4+ and
CCR8+ NKT cells and lower frequencies of Th1-related CCR5+
and CXCR3+ NKT subsets among total NKT cells in cord blood
as observed here. CXCR6+ NKT cells were more abundant in
cord blood. CXCL6 is abundantly secreted by the fetal trophoblast
[29], indicating recruitment of cord blood NKT cells to the
materno-fetal interface. Our study further shows that the
frequencies of CCR7 and CXCR5 expressing NKT cells are
higher in cord blood. This is in line with earlier reports of their low
frequencies in adult peripheral blood [28,30], as well as the high
frequency of CD62L+ cord blood NKT cells [20] and indicates
that cord blood NKT cells could home to lymph nodes and B cell
areas, respectively. The simultaneous expression of markers typical
for naı¨ve cells and the memory marker CD45RO as observed by
us and others [5,6] with concomitant high CCR7 expression is
intriguing. It has been shown earlier that the fetus is able to mount
antigen specific immune responses to environmental antigens
[31,32]. Since the expression of CD45RO indicates previous
antigen contact, we speculate that cord blood CD45RO+ NKT
cells are functionally mature and migrate to lymphatic tissue to
ensure tolerance during in utero exposure to antigens. Even though
the chemokine receptor profile is obviously different between cord
blood and peripheral NKT cells, is has not been studied if the
chemokine receptors on cord blood NKT cells are functionally
active and mediate cellular migration.
Because most chemokines are ligands for several receptors to
define the functionality of specific receptors would involve
migration assays with NKT cells sorted according to the select
chemokine receptors. However, due to the limited amount of
NKT cells in cord blood this approach is not feasible. Migration
assays combined with blocking of specific chemokine/chemokine
receptor interactions could help resolve this issue. Yet, due to the
limited amount of NKT cells in cord blood this approach is highly
challenging.
The low frequency of NKT cells further makes their accurate
quantification difficult. Nonetheless, several facts support the
reliability of our measurements: first, we used very high total
numbers of lymphocytes for flow cytometry; second, the finding
that the majority of cord blood NKT cells was CD4+ is in line with
previous publications [20,21,30,33]; third, higher frequencies of
CCR7+ NKT cells in cord blood were also observed by others
[20]. Contamination with maternal blood cannot be excluded with
certainty based on the analysis of IgA in cord blood. However, due
to the general paucity of NKT cells in blood a transfer of maternal






CCR2 DN IFN 1.00a (0.10–4.17) 0.31 (0.12–4.10) 0.07
IL-4 1.23 (0.00–5.83) 0.28 (0.00–3.35) 0.12
CD4 IFN 0.40 (0.00–2.34) 0.33 (0.10–1.61) 0.43
IL-4 0.28 (0.00–1.73) 0.16 (0.00–0.60) 0.49
CCR3 DN IFN 1.04 (0.10–4.58) 0.43 (0.00–1.03) 0.19
IL-4 0.95 (0.00–6.81) 0.17 (0.00–1.53) ,0.02
CD4 IFN 0.39 (0.00–1.54) 0.46 (0.09–3.34) 0.27
IL-4 0.22 (0.00–0.78) 0.18 (0.00–0.73) 0.70
CCR4 DN IFN 2.30 (0.31–6.47) 0.52 (0.00–2.34) 0.01
IL-4 2.17 (0.37–12.56) 0.21 (0.00–1.55) ,0.001
CD4 IFN 0.60 (0.00–2.10) 0.50 (0.00–1.65) 0.20
IL-4 0.52 (0.00–11.07) 0.29 (0.00–1.01) 0.09
CCR5 DN IFN 0.65 (0.05–3.72) 0.29 (0.23–1.21) 0.66
IL-4 0.89 (0.20–4.66) 0.19 (0.00–1.75) ,0.004
CD4 IFN 0.30 (0.00–1.13) 0.32 (0.00–1.83) 0.50
IL-4 0.25 (0.00–2.00) 0.27 (0.00–0.77) 0.86
CCR6 DN IFN 1.84 (0.10–8.59) 0.91 (0.45–4.07) 0.08
IL-4 2.16 (0.43–14.12) 0.52 (0.13–3.66) ,0.01
CD4 IFN 0.28 (0.00–2.14) 0.42 (0.17–2.47) 0.15
IL-4 0.60 (0.00–2.83) 0.45 (0.12–1.46) 0.85
CCR7 DN IFN 0.34 (0.10–2.56) 0.06 (0.00–0.65) ,0.01
IL-4 0.43 (0.00–2.70) 0.15 (0.00–1.45) ,0.02
CD4 IFN 0.16 (0.00–3.00) 0.16 (0.00–1.42) 0.80
IL-4 0.28 (0.00–0.66) 0.10 (0.00–0.72) 0.19
CCR8 DN IFN 0.87 (0.14–2.80) 0.43 (0.00–3.17) 0.11
IL-4 0.94 (0.40–5.29) 0.27 (0.00–1.82) ,0.01
CD4 IFN 0.16 (0.00–1.07) 0.30 (0.00–1.18) 0.14
IL-4 0.16 (0.00–2.07) 0.03 (0.00–0.60) 0.20
CCR9 DN IFN 1.74 (0.00–9.15) 0.88 (0.37–5.25) 0.25
IL-4 1.82 (0.14–9.86) 0.92 (0.19–6.27) 0.14
CD4 IFN 0.22 (0.00–1.02) 0.39 (0.00–0.88) 0.12
IL-4 0.17 (0.00–3.58) 0.40 (0.00–1.65) 0.19
CXCR3 DN IFN 1.23 (0.08–6.54) 0.45 (0.00–1.54) 0.11
IL-4 1.01 (0.00–6.13) 0.63 (0.11–1.86) 0.16
CD4 IFN 0.32 (0.00–1.53) 0.58 (0.06–2.11) 0.06
IL-4 0.10 (0.00–3.64) 0.50 (0.16–1.17) 0.02
CXCR4 DN IFN 2.33 (0.67–13.82) 0.93 (0.00–6.46) 0.01
IL-4 3.29 (1.06–15.15) 0.76 (0.00–7.73) ,0.01
CD4 IFN 0.23 (0.00–2.52) 0.26 (0.00–1.29) 0.98
IL-4 0.18 (0.00–2.86) 0.20 (0.00–1.65) 0.64
aData are shown as medians with (min-max.).
doi:10.1371/journal.pone.0015714.t002
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NKT cells to the fetus in the quantities measured here seems
unlikely. Furthermore, CD45RO expression on cord blood NKT
cells has been reported also by others [5,6].
The observed chemokine receptors expression pattern indicates
Th2-biased functions of cord blood NKT cells which were further
substantiated by the IL-4/IFN-c secretion patterns of cord blood
NKT cells. Within total NKT cells, IL-4 producing NKT cells
were more frequent in cord blood compared to adult peripheral
blood, in accordance with a previous report [34]. Within the DN
subset the higher frequency of IL-4 production was not limited to
NKT cells expressing Th2-associated CCR4 and CCR8, but
occurred in the majority of DN NKT cell subsets. Of note, the
stimulation protocol used here, rather reflects the general
disposition of NKT cells to produce certain cytokines but does
not give information whether they behave in the same manner in
utero during normal pregnancies. Finally, a comparatively small
number of newborns was analyzed which reduces the power to
detect small but potentially important differences. Therefore, it is
possible that some findings were by chance. On the other hand,
the size of differences between cord blood and peripheral NKT
cells was rather high which argues for their biological relevance.
For this reason, it seems unlikely that the analysis of a larger
sample size would have yielded substantially different results.
Based on the analysis of chemokine receptor expression patterns
and IL-4/IFN-c secretion, cord blood NKT cells constitute a
heterogeneous population. Single NKT cell subsets might have
different specialized immune regulatory functions during fetal life.
Yet, despite this heterogeneity, we observed a clear Th2-bias
mainly in the DN subset. Therefore, we speculate that NKT cells
are important for the initiation and control of the cord blood Th2
environment which is needed to maintain tolerance towards self-
antigens as well as non-inherited maternal antigens. Moreover, a
NKT mediated Th2 bias may also be important in the early post-
natal period to prevent overactive immune responses during early
extrauterine exposures towards ubiquitous antigens.
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